Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 2).

Authors

R Patarca
A Isava
R Campo
N J. Rodriguez
E Nunez
M Alter
M Marchette
M M. Sanabia
Christopher Mitchell
D Rivera
G Scott
D Jayaweera
J Moreno
C Boulanger

Publication Title

Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer

ISSN

0731-8898

Publication Date

1-1-2003

Volume

22

Issue

4

First Page

235

Last Page

79

Disciplines

Medical Specialties | Medicine and Health Sciences | Osteopathic Medicine and Osteopathy

NSUWorks Citation

Patarca, R; Isava, A; Campo, R; Rodriguez, N J.; Nunez, E; Alter, M; Marchette, M; Sanabia, M M.; Mitchell, Christopher; Rivera, D; Scott, G; Jayaweera, D; Moreno, J; and Boulanger, C, "Human immunodeficiency virus type 1 pharmacogenomics in clinical practice: relevance of HIV-1 drug resistance testing (Part 2)." (2003). Faculty Articles. 951.
https://nsuworks.nova.edu/hpd_com_faculty_articles/951